跳至主要内容
临床试验/NCT04766255
NCT04766255招募中4 期

Behavioral Comparison of Three Different Graft Materials to Increase Soft Tissue Thickness Around Dental Implants in Terms of Volume Gain and Stability Over Time: A Randomized Clinical Trial.

Universitat Internacional de Catalunya1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年5月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
招募中
入组人数
60
试验地点
1
主要终点
soft tissue volume gain

研究概览

简要总结

The purpose of the study is to compare soft tissue volume changes in terms of volume gain and stability around dental implants and PROMS in cases where a sub-epithelial connective tissue graft (SCTG) from the palate, Porcine collagen matrix (CM) or Porcine Acellular dermal matrix (PADM) is used after 3 and 15 months after implant placement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients referred to Department of Periodontology (CUO) in need of a single implant and need of soft tissue augmentation such as buccal defects, thin biotype, lack of keratinized tissue and aesthetic compromised situation.
  • •The patient must be ≥18 years and able to understand the nature of the proposed surgery and must sign an informed consent.
  • •The implant must be located between 2 fixed reference points (i.e. clinical crowns).
  • •Anterior and premolar teeth (from premolar to premolar).
  • •Enough crestal bone width to leave a minimum thickness of 2mm at the buccal bone plate when placing the implant.
  • •Palate must have ≥2mm of thickness at premolar area.
  • •Full mouth plaque and bleeding score <20%.

排除标准

  • •Pregnant or lactation.
  • •Active periodontal disease.
  • •Previous soft tissue augmentation in the area.
  • •Need of guided bone regeneration (GBR) during or after the placement of the implant.
  • •Heavy smokers (> 10 cigarettes per day).
  • •Local or systemic conditions that would interfere with routine periodontal therapy (non-controlled diabetes mellitus, cancer, HIV, Chronic High dose steroid therapy, bone metabolic diseases, radiation, immunosuppressive disorders, liver function disorder, immunosuppressant disease, autoimmune disease).
  • •Allergy to non-steroidal anti-inflammatory drugs.
  • •Patients taking medications that cause gingival enlargement.

研究组 & 干预措施

Control Group

Active Comparator

Implant placement and prosthetic rehabilitation of the missing tooth

干预措施: Implant Placement (Procedure)

SCTG group

Experimental

Implant placement, soft tissue augumentation of Connective Tissue Graft (from the palate) (SCTG) at the implant site and prosthetic rehabilitation of the missing tooth.

干预措施: Implant Placement (Procedure)

SCTG group

Experimental

Implant placement, soft tissue augumentation of Connective Tissue Graft (from the palate) (SCTG) at the implant site and prosthetic rehabilitation of the missing tooth.

干预措施: Soft Tissue graft augmentation (Procedure)

CM group

Experimental

Implant placement, soft tissue augumentation of porcine collagen matrix (CM) at the implant site and prosthetic rehabilitation of the missing tooth.

干预措施: Soft Tissue graft augmentation (Procedure)

CM group

Experimental

Implant placement, soft tissue augumentation of porcine collagen matrix (CM) at the implant site and prosthetic rehabilitation of the missing tooth.

干预措施: Implant Placement (Procedure)

PADM group

Experimental

Implant placement, soft tissue augumentation of Porcine acellular dermal matrix (PADM) at the implant site and prosthetic rehabilitation of the missing tooth.

干预措施: Soft Tissue graft augmentation (Procedure)

PADM group

Experimental

Implant placement, soft tissue augumentation of Porcine acellular dermal matrix (PADM) at the implant site and prosthetic rehabilitation of the missing tooth.

干预措施: Implant Placement (Procedure)

结局指标

主要结局

soft tissue volume gain

时间窗: after 3 months

Optical scans superposition

次要结局

  • soft tissue volume stability(after 15 months)
  • Width of keratinized tissue (KT)(at baseline, after 12 weeks and after 15 months.)
  • Bleeding on probing (BI)(at baseline, after 12 weeks and after 15 months.)
  • Probing depth (PD)(at baseline, after 12 weeks and after 15 months.)
  • Patient reported outcome measures (PROMs)(after the surgery procedures (baseline) and after 7 days (suture removal))
  • Plaque index (PI)(at baseline, after 12 weeks and after 15 months.)
  • Phenotype evaluation (PT)(at baseline, after 12 weeks and after 15 months.)
  • Pink Esthetic Score (PES)(After 2 weeks of the definite crown placement (around 16 months))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andres Pascual La Rocca

Master in Periodontics program director

Universitat Internacional de Catalunya

研究点 (1)

Loading locations...

相似试验